<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-10-22 14:28:42Autoinflammatory syndromes Periodic fever syndrome Muckle–Wells syndrome NALP3 Hyper-IgD syndrome Familial cold urticaria Familial Mediterranean fever Neonatal onset multisystem inflammatory disease Periodic fever aphthous stomatitis pharyngitis and adenitis Health Medicine Rheumatology |
Add to Reading List |
Microsoft Word - PFS DQ.doc | Public Summary Document – November 2014 PBAC Meeting 5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes;DocID: 12wgH - View Document |
| 5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of ApplicationDocID: 12oEM - View Document |
| Microsoft Word - CAPS_sospeso.docDocID: vcfk - View Document |
| PRIOR AUTHORIZATION POLICY Ilaris® (canakinumab for subcutaneous [SC] injection Novartis) To initiate a Coverage Review, Call[removed]DocID: stIC - View Document |
| Fever study aims to get faster treatment for children Periodic fever syndromes represent a group of rare, inflammatory disorders that often begin in childhood. In most affected children, they present as a seemingly unproDocID: raQM - View Document |